Brought to you by 
Neurology firm Link Medicine raises $20mm in Series D round
07 May 2010
Executive Summary
In what appears to be its Series D financing, Link Medicine Corp. (addressing Parkinson's, Alzheimer's, and other neurodegenerative diseases at their origin--toxic protein aggregation) has brought in $20mm from nine backers. The company raised $40mm in a Series C round less than two years ago.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neurology firm Link Medicine raises $20mm in Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice